GlassScriptPhysician profile
David A Ballance
NPI 1881654820
$1,269.73
in general payments reported to CMS, 2019-2025
20 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $220 · 2021: $296 · 2022: $204 · 2023: $44.76 · 2024: $128 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.41 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $375.91 | 2021-2024 | Ubrelvy, Qulipta |
| Allergan, INC. | $209.02 | 2019-2020 | |
| Lilly USA, LLC | $88.78 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $71.37 | 2019-2025 | |
| Exact Sciences Corporation | $70.73 | 2024-2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $70.07 | 2019-2022 | |
| Amgen INC. | $64.72 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.33 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $44.17 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $42.79 | 2020 | |
| Therapeuticsmd, INC. | $26.80 | 2022 | |
| Astellas Pharma US INC | $24.21 | 2024 | Veozah |
| Mylan Specialty L.P. | $22.88 | 2024 | Yupelri |
| Mayne Pharma Commercial LLC | $22.07 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.81 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.96 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.01 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.83 | 2019 | |
| Eisai INC. | $12.68 | 2021 | |
| Corium, LLC | $5.59 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ballance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.